Case_id: case_382
Case_description: 
A 32-year-old woman comes to the physician because she feels depressed, has difficulty sleeping, a poor appetite, and low concentration for the past 3 months. During this time, she has also had low energy and lost interest in playing the guitar. During high school, the patient went through similar episodes of low mood and poor sleep. At that time, she would repeatedly engage in binge eating and purging behavior, for which she was referred to therapy. There is no evidence of suicidal ideation. The physician offers to prescribe a medication for her current symptoms. Treatment with which of the following drugs should most be avoided in this patient?
Options: 
1. Duloxetine
2. Trazodone
3. Bupropion
4. Mirtazapine
5. Citalopram
Correct Answer: Bupropion

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 3 (Bupropion)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient Information:** 32-year-old woman.  
- **Chief Complaint:** Feelings of depression lasting 3 months.  
- **Key Clinical Manifestations:**  
  - Depressed mood  
  - Difficulty sleeping  
  - Poor appetite  
  - Low concentration  
  - Low energy  
  - Anhedonia (lost interest in playing the guitar)  
- **Past Psychiatric History:** Similar depressive episodes during high school with binge eating and purging behaviors, indicative of an eating disorder (likely bulimia nervosa). Referred to therapy at that time.  
- **Safety Concerns:** No evidence of suicidal ideation.

**2. Analysis of Clinical Features**  
- **Duration and Timeline:** Current depressive symptoms have persisted for 3 months, indicating a possible major depressive disorder (MDD). Past episodes during high school suggest a recurrent pattern.  
- **Symptomatology:** The presence of depressed mood, insomnia, anorexia, reduced concentration, low energy, and anhedonia align with typical features of MDD.  
- **Historical Factors:** Previous engagement in binge eating and purging behaviors suggest a comorbid eating disorder, likely bulimia nervosa. This history is crucial for medication considerations due to potential contraindications.  
- **Interconnections:** The chronicity and recurrence of depressive symptoms may indicate an underlying vulnerability to mood disorders, potentially intertwined with her eating disorder history.  
- **Rule-Outs:** Absence of psychotic features or suicidal ideation narrows the focus to treating depressive symptoms without immediate need for interventions targeting acute psychosis or suicidality.

**3. Differential Diagnosis Analysis**  
- **Option 1: Duloxetine**  
  - **Use:** SNRI antidepressant effective for MDD and anxiety disorders.  
  - **Consideration:** Generally safe for patients with a history of eating disorders.  
- **Option 2: Trazodone**  
  - **Use:** Often used for depression and as a sleep aid due to its sedative properties.  
  - **Consideration:** Suitable for treating insomnia and depressive symptoms without significant interaction with eating disorders.  
- **Option 3: Bupropion**  
  - **Use:** NDRI antidepressant useful for MDD and smoking cessation.  
  - **Consideration:** **Contraindicated in patients with bulimia nervosa or bulimic behaviors** due to an increased risk of seizures, especially pertinent given the patient's history of purging behaviors.  
- **Option 4: Mirtazapine**  
  - **Use:** Tetracyclic antidepressant effective for MDD, especially when appetite stimulation is desired.  
  - **Consideration:** Appropriate for depressive symptoms and can aid in improving appetite without exacerbating eating disorders.  
- **Option 5: Citalopram**  
  - **Use:** SSRI antidepressant commonly prescribed for MDD and anxiety disorders.  
  - **Consideration:** Safe for use in patients with a history of eating disorders, with no specific contraindications related to bulimia.

**4. Final Selection**  
**My final selection is: Option 3 (Bupropion)(安非他酮)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 3 (Bupropion)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Basic Information**: 32-year-old woman presenting with 3-month history of depression, insomnia, poor appetite, low energy, and anhedonia (loss of interest in playing the guitar).  
- **Key Symptoms**: Persistent low mood, fatigue, cognitive impairment (concentration difficulties), and a history of binge eating/purging during prior depressive episodes in adolescence.  
- **Decisive Features**: Recurrent depressive episodes with associated binge eating and purging, suggesting a history of bulimia nervosa.  

---

**2. Analysis of Clinical Features**  
- **Timeline**: Current depressive symptoms (3 months) align with past episodes during high school, which were accompanied by binge eating and purging. This pattern supports a diagnosis of recurrent major depressive disorder with comorbid bulimia nervosa.  
- **Interrelationships**: The current low energy and anhedonia are classic depressive symptoms, while the history of binge eating/purging indicates a vulnerability to disordered eating behaviors.  
- **Critical Consideration**: The patient’s history of purging behaviors suggests caution in prescribing medications that could exacerbate eating disorders or trigger binge-eating episodes.  

---

**3. Differential Diagnosis Analysis**  
- **Duloxetine (Option 1)**: A serotonin-norepinephrine reuptake inhibitor (SNRI). It is effective for depression but may cause nausea or appetite changes. No strong contraindication for bulimia nervosa.  
- **Trazodone (Option 2)**: An antidepressant primarily used for insomnia. It may cause weight gain but is not typically associated with exacerbating eating disorders.  
- **Bupropion (Option 3)**: A norepinephrine-dopamine reuptake inhibitor (NDRI). It is generally weight-neutral or suppresses appetite. However, **bupropion is contraindicated in patients with a history of anorexia nervosa or bulimia nervosa due to its potential to worsen disordered eating behaviors or trigger purging**.  
- **Mirtazapine (Option 4)**: A tetracyclic antidepressant with appetite-stimulating effects. It could benefit the patient’s poor appetite and insomnia, making it a safer choice in this context.  
- **Citalopram (Option 5)**: A selective serotonin reuptake inhibitor (SSRI). It is commonly used for depression and generally safe, though it may cause mild appetite changes without specific risks for bulimia nervosa.  

---

**4. Final Selection**  
**My final selection is: Option 3 (Bupropion) (盐酸安非他酮)**  

**Key Evidence**:  
- Bupropion’s mechanism of action (norepinephrine-dopamine reuptake inhibition) may exacerbate disordered eating behaviors or trigger binge-purge cycles in patients with a history of bulimia nervosa.  
- Clinical guidelines and studies caution against its use in individuals with active or past eating disorders due to potential worsening of symptoms.  
- The patient’s history of binge eating/purging during prior depressive episodes makes her particularly vulnerable to this risk.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 3 (Bupropion)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient**: 32-year-old woman.  
- **Chief Complaint**: Depressed mood, insomnia, poor appetite, low concentration, anhedonia (loss of interest in guitar), low energy (3-month duration).  
- **Key Clinical Manifestations**:  
  - Current symptoms meet criteria for major depressive disorder (MDD).  
  - History of recurrent depressive episodes (similar symptoms in high school).  
  - Past binge eating and purging behaviors (eating disorder-like behavior).  
  - No suicidal ideation.  

**2. Analysis of Clinical Features**  
- **Timeline**: Chronic, recurrent depression (episodes in adolescence and current episode).  
- **Critical Features**:  
  - **Depressive Symptoms**: Persistent low mood, anhedonia, insomnia, appetite/weight changes, fatigue, and concentration issues.  
  - **Eating Disorder History**: Binge eating and purging (bulimia-like behavior).  
- **Interrelationships**:  
  - Depression and eating disorders are often comorbid.  
  - Past purging behaviors (e.g., vomiting, laxative use) may predispose to electrolyte imbalances (e.g., hypokalemia), increasing seizure risk.  

**3. Differential Diagnosis Analysis**  
- **Bupropion (Option 3)**:  
  - **Contraindication**: Lowers seizure threshold, especially in patients with eating disorders (bulimia, anorexia) due to electrolyte disturbances from purging.  
  - **Risk**: Even if the eating disorder is in remission, historical purging increases vulnerability to seizures.  
- **Other Options**:  
  - **Duloxetine (1)/Citalopram (5)**: SSRIs/SNRIs are first-line for MDD and safe in this context.  
  - **Trazodone (2)**: Used for insomnia; no seizure risk concern.  
  - **Mirtazapine (4)**: Appetite-stimulating effects may benefit poor appetite; no seizure risk.  

**4. Final Selection**  
**My final selection is: Option 3 (Bupropion)(安非他酮)**  
- **Key Evidence**:  
  - Bupropion is contraindicated in patients with a history of binge eating/purging due to increased seizure risk.  
  - Clinical guidelines explicitly warn against its use in active or historical eating disorders with purging behaviors.  
  - Other options lack this specific contraindication and are safer for this patient.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 3 (Bupropion)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option3

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option3 - Bupropion
Correct Answer: - Bupropion

Is the final diagnosis correct? ✓ Correct

